Stevanato Group S.p.A STVN
NYSE STVN
$22.60 +0.25 (+1.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026)

Stevanato Group S.p.A (STVN) posted quarterly Cash from Financing Activities of -$29.2 million for Q1 2026, up 22.49% year-over-year from -$23.8 million in Q1 2025, and down 245.6% quarter-over-quarter from $20.0 million in Q4 2025.

Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Stevanato Group S.p.A (STVN) has reported Cash from Financing Activities for 7 consecutive years, with -$29.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 22.49% year-over-year to -$29.2 million; the TTM figure through Mar 2026 stood at $37.5 million (up 2306.28% YoY), while the FY2025 annual figure was $25.7 million, down 86.86% from the prior year.
  • Cash from Financing Activities fell to -$29.2 million in Q1 2026 per STVN's latest filing, from $20.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $159.5 million in Q1 2024 and bottomed at -$64.0 million in Q2 2024.
  • Historically, Cash from Financing Activities has averaged $19.0 million across 5 years, with a median of $8.6 million in 2023.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 1758.04% — and 2025, when it sank 123.57%.
  • Stevanato Group S.p.A's Cash from Financing Activities stood at -$19.0 million in 2022, then soared by 597.24% to $94.4 million in 2023, then fell by 24.92% to $70.8 million in 2024, then tumbled by 71.74% to $20.0 million in 2025, then tumbled by 245.6% to -$29.2 million in 2026.
  • Business Quant data shows STVN's Cash from Financing Activities at -$29.2 million in Q1 2026, $20.0 million in Q4 2025, and $22.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -287.90 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -577.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -510.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -263.16 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -159.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -164.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -300.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -75.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -31.00 Mn
10 Stevanato Group S.p.A 6.18 Bn 6.07 Bn 100.91 Mn -2.17 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.17 Mn
Jun 30, 2026 -2.17 Mn
Mar 31, 2026 -29.15 Mn
Mar 31, 2026 -29.15 Mn
Dec 31, 2025 20.02 Mn
Dec 31, 2025 20.02 Mn
Sep 30, 2025 22.68 Mn
Sep 30, 2025 22.68 Mn
Jun 30, 2025 24.00 Mn
Jun 30, 2025 24.00 Mn
Mar 31, 2025 -37.61 Mn
Mar 31, 2025 -37.61 Mn
Dec 31, 2024 70.85 Mn
Dec 31, 2024 70.85 Mn
Sep 30, 2024 32.29 Mn
Sep 30, 2024 32.29 Mn
Jun 30, 2024 -63.97 Mn
Jun 30, 2024 -63.97 Mn
Mar 31, 2024 159.55 Mn
Mar 31, 2024 159.55 Mn